Melissa Pavilack Kirker
AuthID: R-00K-YKF
1
TITLE: Evaluating Real-World Characteristics of Patients With Advanced Urothelial Carcinoma Eligible for Avelumab Maintenance Therapy: A Multicountry Retrospective Medical Chart Review
AUTHORS: Bellmunt, Joaquim; Chang, Jane; Pavilack Kirker, Melissa; Cappelleri, Joseph C.; Costa, Nuno; Esterberg, Elizabeth; Kearney, Mairead; Hitchens, Abigail; Candrilli, Sean D.; Ajmera, Mayank;
PUBLISHED: 2023, SOURCE: CLINICAL GENITOURINARY CANCER, VOLUME: 21, ISSUE: 4
AUTHORS: Bellmunt, Joaquim; Chang, Jane; Pavilack Kirker, Melissa; Cappelleri, Joseph C.; Costa, Nuno; Esterberg, Elizabeth; Kearney, Mairead; Hitchens, Abigail; Candrilli, Sean D.; Ajmera, Mayank;
PUBLISHED: 2023, SOURCE: CLINICAL GENITOURINARY CANCER, VOLUME: 21, ISSUE: 4
INDEXED IN: 
Scopus 
WOS
Scopus WOS2
TITLE: Estimated net benefit of avelumab (AVE) plus best supportive care (BSC) vs BSC alone for patients (pts) with advanced urothelial carcinoma (aUC) using a quality-adjusted time without cancer symptoms or toxicity (Q-TWiST) analysis.
AUTHORS: Powles, Thomas; Cislo, Paul; Kirker, Melissa; Chang, Jane; Gharibian, Norbek; Thompson, Allison; Costa, Nuno; Grivas, Petros;
PUBLISHED: 2023, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 41, ISSUE: 16
AUTHORS: Powles, Thomas; Cislo, Paul; Kirker, Melissa; Chang, Jane; Gharibian, Norbek; Thompson, Allison; Costa, Nuno; Grivas, Petros;
PUBLISHED: 2023, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 41, ISSUE: 16
INDEXED IN: WOS
WOS